Cargando…
Time to Surgery Does Not Affect Overall or Disease-Free Survival of Patients with Primary Resectable PDAC
(1) Background: Delay in therapy for pancreatic ductal adenocarcinoma (PDAC) may contribute to a worse outcome. The aim of this study was to investigate the prognostic value of time from diagnosis to surgery in patients undergoing upfront surgery for primarily resectable pancreatic carcinoma. (2) Me...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9369379/ https://www.ncbi.nlm.nih.gov/pubmed/35956049 http://dx.doi.org/10.3390/jcm11154433 |
_version_ | 1784766438584614912 |
---|---|
author | Jacobsen, Anne Hobbs, Mirianna Merkel, Susanne Mittelstädt, Anke Czubayko, Franziska Krautz, Christian Weber, Georg F. Grützmann, Robert Brunner, Maximilian |
author_facet | Jacobsen, Anne Hobbs, Mirianna Merkel, Susanne Mittelstädt, Anke Czubayko, Franziska Krautz, Christian Weber, Georg F. Grützmann, Robert Brunner, Maximilian |
author_sort | Jacobsen, Anne |
collection | PubMed |
description | (1) Background: Delay in therapy for pancreatic ductal adenocarcinoma (PDAC) may contribute to a worse outcome. The aim of this study was to investigate the prognostic value of time from diagnosis to surgery in patients undergoing upfront surgery for primarily resectable pancreatic carcinoma. (2) Methods: This retrospective single-center study included 214 patients who underwent primary resection of PDAC from January 2000 to December 2018 at University Hospital Erlangen. Using a minimum p-value approach, patients were stratified according to time to surgery (TtS) into two groups: TtS ≤ 23 days and TtS > 23 days. Postoperative outcome and long-term survival were compared. (3) Results: Median TtS was 25 days. The best cut-off for TtS was determined as 23 days. There were no differences regarding postoperative outcome or overall survival (OS) and disease-free survival (DFS) (OS: 23.8 vs. 20.4 months, p = 0.210, respectively, and DFS: 15.8 vs. 13.6 months, p = 0.187). Multivariate analysis revealed age, lymph node metastasis, tumor differentiation and resection status as significant independent prognostic predictors for OS and DFS. (4) Conclusions: A delay of surgery > 23 days after first diagnosis does not affect overall or disease-free survival of patients with primary resectable PDAC. However, the psychological impact of a delay to patients waiting for surgery should not be underestimated. |
format | Online Article Text |
id | pubmed-9369379 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-93693792022-08-12 Time to Surgery Does Not Affect Overall or Disease-Free Survival of Patients with Primary Resectable PDAC Jacobsen, Anne Hobbs, Mirianna Merkel, Susanne Mittelstädt, Anke Czubayko, Franziska Krautz, Christian Weber, Georg F. Grützmann, Robert Brunner, Maximilian J Clin Med Article (1) Background: Delay in therapy for pancreatic ductal adenocarcinoma (PDAC) may contribute to a worse outcome. The aim of this study was to investigate the prognostic value of time from diagnosis to surgery in patients undergoing upfront surgery for primarily resectable pancreatic carcinoma. (2) Methods: This retrospective single-center study included 214 patients who underwent primary resection of PDAC from January 2000 to December 2018 at University Hospital Erlangen. Using a minimum p-value approach, patients were stratified according to time to surgery (TtS) into two groups: TtS ≤ 23 days and TtS > 23 days. Postoperative outcome and long-term survival were compared. (3) Results: Median TtS was 25 days. The best cut-off for TtS was determined as 23 days. There were no differences regarding postoperative outcome or overall survival (OS) and disease-free survival (DFS) (OS: 23.8 vs. 20.4 months, p = 0.210, respectively, and DFS: 15.8 vs. 13.6 months, p = 0.187). Multivariate analysis revealed age, lymph node metastasis, tumor differentiation and resection status as significant independent prognostic predictors for OS and DFS. (4) Conclusions: A delay of surgery > 23 days after first diagnosis does not affect overall or disease-free survival of patients with primary resectable PDAC. However, the psychological impact of a delay to patients waiting for surgery should not be underestimated. MDPI 2022-07-29 /pmc/articles/PMC9369379/ /pubmed/35956049 http://dx.doi.org/10.3390/jcm11154433 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Jacobsen, Anne Hobbs, Mirianna Merkel, Susanne Mittelstädt, Anke Czubayko, Franziska Krautz, Christian Weber, Georg F. Grützmann, Robert Brunner, Maximilian Time to Surgery Does Not Affect Overall or Disease-Free Survival of Patients with Primary Resectable PDAC |
title | Time to Surgery Does Not Affect Overall or Disease-Free Survival of Patients with Primary Resectable PDAC |
title_full | Time to Surgery Does Not Affect Overall or Disease-Free Survival of Patients with Primary Resectable PDAC |
title_fullStr | Time to Surgery Does Not Affect Overall or Disease-Free Survival of Patients with Primary Resectable PDAC |
title_full_unstemmed | Time to Surgery Does Not Affect Overall or Disease-Free Survival of Patients with Primary Resectable PDAC |
title_short | Time to Surgery Does Not Affect Overall or Disease-Free Survival of Patients with Primary Resectable PDAC |
title_sort | time to surgery does not affect overall or disease-free survival of patients with primary resectable pdac |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9369379/ https://www.ncbi.nlm.nih.gov/pubmed/35956049 http://dx.doi.org/10.3390/jcm11154433 |
work_keys_str_mv | AT jacobsenanne timetosurgerydoesnotaffectoverallordiseasefreesurvivalofpatientswithprimaryresectablepdac AT hobbsmirianna timetosurgerydoesnotaffectoverallordiseasefreesurvivalofpatientswithprimaryresectablepdac AT merkelsusanne timetosurgerydoesnotaffectoverallordiseasefreesurvivalofpatientswithprimaryresectablepdac AT mittelstadtanke timetosurgerydoesnotaffectoverallordiseasefreesurvivalofpatientswithprimaryresectablepdac AT czubaykofranziska timetosurgerydoesnotaffectoverallordiseasefreesurvivalofpatientswithprimaryresectablepdac AT krautzchristian timetosurgerydoesnotaffectoverallordiseasefreesurvivalofpatientswithprimaryresectablepdac AT webergeorgf timetosurgerydoesnotaffectoverallordiseasefreesurvivalofpatientswithprimaryresectablepdac AT grutzmannrobert timetosurgerydoesnotaffectoverallordiseasefreesurvivalofpatientswithprimaryresectablepdac AT brunnermaximilian timetosurgerydoesnotaffectoverallordiseasefreesurvivalofpatientswithprimaryresectablepdac |